← Back to News

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

March 29, 2023

Describing the development of our lead asset SQ3370, from preclinical work through our Phase 1 clinical trial.

This is the first example of click chemistry being used inside the human body. We have demonstrated that we are able to selectively use and control chemistry inside the human body, a process that is truly bioorthogonal to all other cellular processes.

Read more here

Want to stay up to date on our news? 
Follow us on LinkedIn